{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:42:57Z","timestamp":1791434577396,"version":"4.3.3"},"reference-count":92,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH","doi-asserted-by":"publisher","award":["K08CA222620"],"award-info":[{"award-number":["K08CA222620"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Adrenocortical carcinoma (ACC) is a rare endocrine malignancy that affects patients across the age spectrum. Although the overall survival in patients with ACC is poor, there is significant heterogeneity in terms of outcomes, presentation, and underlying genetic drivers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Acquisition<\/jats:title>\n                  <jats:p>This review is based on the evidence collected from primary research studies, expert reviews, and published guidelines. The studies were identified through PubMed search with key words \u201cadrenocortical carcinoma,\u201d \u201cprognosis,\u201d \u201cpathology,\u201d and \u201cgenetics.\u201d The PubMed search was complemented by authors\u2019 expertise, research, and clinical experience in the field of ACC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Synthesis<\/jats:title>\n                  <jats:p>Identification of biomarkers has been critical to gain better insight into tumor behavior and to guide therapeutic approach to patients. Tumor stage, resection status, and Ki67 are pathological tumor characteristics that have been identified as prognosticators in patients with ACC. Cortisol excess also correlates with worse prognosis. Clinical and histopathological characteristics help stratify patient outcomes, yet still up to 25% of patients have a different outcome than predicted. To bridge this gap, comprehensive genomic profiling studies have characterized additional profiles that correlate with clinical outcomes. In addition, studies of clinically applicable molecular markers are under way to further stratify outcomes in patients with ACC tumors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Clinical predictors in combination with pathological markers play a critical role in the approach to patients with ACC. Recent advances in genetic prognosticators will help extend the stratification of these tumors and contribute to a personalized therapeutic approach to patients with ACC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab866","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T15:04:35Z","timestamp":1638371075000},"page":"1159-1169","source":"Crossref","is-referenced-by-count":24,"title":["Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma"],"prefix":"10.1210","volume":"107","author":[{"given":"Michael R","family":"Clay","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Colorado School of Medicine at Colorado Anschutz Medical Campus Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia M","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Pathology; St. Jude Children\u2019s Research Hospital, Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8151-5107","authenticated-orcid":false,"given":"Lauren","family":"Fishbein","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine at Colorado Anschutz Medical Campus Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2262-0011","authenticated-orcid":false,"given":"Tobias","family":"Else","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-582X","authenticated-orcid":false,"given":"Katja","family":"Kiseljak-Vassiliades","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine at Colorado Anschutz Medical Campus Aurora, CO, USA"},{"name":"Research Service Veterans Affairs Medical Center, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"issue":"2","key":"2022032516104596400_CIT0001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev."},{"issue":"5","key":"2022032516104596400_CIT0002","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol."},{"issue":"6","key":"2022032516104596400_CIT0003","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022032516104596400_CIT0004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","article-title":"Clinical management of adrenocortical carcinoma","volume":"23","author":"Fassnacht","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"5","key":"2022032516104596400_CIT0005","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J Surg."},{"issue":"8","key":"2022032516104596400_CIT0006","doi-asserted-by":"crossref","first-page":"636","DOI":"10.14740\/jocmr3503w","article-title":"The characteristics and trends in adrenocortical carcinoma: a United States population based study","volume":"10","author":"Sharma","year":"2018","journal-title":"J Clin Med Res."},{"issue":"5","key":"2022032516104596400_CIT0007","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jpedsurg.2013.02.017","article-title":"Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study","volume":"48","author":"McAteer","year":"2013","journal-title":"J Pediatr Surg."},{"issue":"5","key":"2022032516104596400_CIT0008","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00345-012-1011-1","article-title":"Adrenal tumours are more predominant in females regardless of their histological subtype: a review","volume":"31","author":"Audenet","year":"2013","journal-title":"World J Urol."},{"issue":"1","key":"2022032516104596400_CIT0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(05)64023-2","article-title":"Adrenocortical carcinoma: diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J Urol."},{"issue":"5","key":"2022032516104596400_CIT0010","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","article-title":"Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry","volume":"22","author":"Michalkiewicz","year":"2004","journal-title":"J Clin Oncol."},{"issue":"16","key":"2022032516104596400_CIT0011","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"10","key":"2022032516104596400_CIT0012","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1210\/jcem.86.10.7957","article-title":"An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors","volume":"86","author":"Latronico","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022032516104596400_CIT0013","doi-asserted-by":"crossref","first-page":"101448","DOI":"10.1016\/j.beem.2020.101448","article-title":"Pediatric adrenocortical tumours","volume":"34","author":"Pinto","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"7","key":"2022032516104596400_CIT0014","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","article-title":"Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients","volume":"27","author":"Wieneke","year":"2003","journal-title":"Am J Surg Pathol."},{"key":"2022032516104596400_CIT0015","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun."},{"issue":"6","key":"2022032516104596400_CIT0016","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet."},{"issue":"5","key":"2022032516104596400_CIT0017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell."},{"key":"2022032516104596400_CIT0018","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2015.00023","article-title":"Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors","volume":"6","author":"Lalli","year":"2015","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"2022032516104596400_CIT0019","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1210\/en.2004-1385","article-title":"Minireview: transcriptional regulation of adrenocortical development","volume":"146","author":"Hammer","year":"2005","journal-title":"Endocrinology."},{"issue":"35","key":"2022032516104596400_CIT0020","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1200\/JCO.2017.74.2460","article-title":"Identification of clinical and biologic correlates associated with outcome in children with adrenocortical tumors without germline TP53 mutations: a St Jude Adrenocortical Tumor Registry and Children\u2019s Oncology Group Study","volume":"35","author":"Pinto","year":"2017","journal-title":"J Clin Oncol."},{"issue":"6","key":"2022032516104596400_CIT0021","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a Children\u2019s Oncology Group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J Clin Oncol."},{"issue":"6","key":"2022032516104596400_CIT0022","first-page":"1365","article-title":"Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome","volume":"43","author":"Li","year":"1969","journal-title":"J Natl Cancer Inst."},{"issue":"4985","key":"2022032516104596400_CIT0023","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science."},{"issue":"5","key":"2022032516104596400_CIT0024","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrclinonc.2014.41","article-title":"Li-Fraumeni syndrome: cancer risk assessment and clinical management","volume":"11","author":"McBride","year":"2014","journal-title":"Nat Rev Clin Oncol."},{"issue":"1","key":"2022032516104596400_CIT0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10689-020-00207-z","article-title":"New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer","volume":"20","author":"Evans","year":"2021","journal-title":"Fam Cancer."},{"issue":"10","key":"2022032516104596400_CIT0026","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","article-title":"Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes","volume":"28","author":"Frebourg","year":"2020","journal-title":"Eur J Hum Genet."},{"issue":"5","key":"2022032516104596400_CIT0027","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1590\/S0004-27302004000500009","article-title":"Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors","volume":"48","author":"Pinto","year":"2004","journal-title":"Arq Bras Endocrinol Metabol."},{"issue":"20","key":"2022032516104596400_CIT0028","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1200\/JCO.2012.46.3711","article-title":"Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors","volume":"31","author":"Cust\u00f3dio","year":"2013","journal-title":"J Clin Oncol."},{"issue":"21","key":"2022032516104596400_CIT0029","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1002\/cncr.33143","article-title":"What 20 years of research has taught us about the TP53 p.R337H mutation","volume":"126","author":"Pinto","year":"2020","journal-title":"Cancer."},{"issue":"26","key":"2022032516104596400_CIT0030","doi-asserted-by":"crossref","first-page":"eaba3231","DOI":"10.1126\/sciadv.aba3231","article-title":"XAF1 as a modifier of p53 function and cancer susceptibility","volume":"6","author":"Pinto","year":"2020","journal-title":"Sci Adv."},{"issue":"3","key":"2022032516104596400_CIT0031","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1210\/jc.2011-1982","article-title":"TP53 germline mutations in adult patients with adrenocortical carcinoma","volume":"97","author":"Herrmann","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022032516104596400_CIT0032","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022032516104596400_CIT0033","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrendo.2017.166","article-title":"Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement","volume":"14","author":"Brioude","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"8","key":"2022032516104596400_CIT0034","doi-asserted-by":"crossref","first-page":"e26432","DOI":"10.1002\/pbc.26432","article-title":"Management of adrenal masses in patients with Beckwith-Wiedemann syndrome","volume":"64","author":"MacFarland","year":"2017","journal-title":"Pediatr Blood Cancer."},{"issue":"24","key":"2022032516104596400_CIT0035","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2012.48.0988","article-title":"Adrenocortical carcinoma is a Lynch syndrome-associated cancer","volume":"31","author":"Raymond","year":"2013","journal-title":"J Clin Oncol."},{"issue":"6","key":"2022032516104596400_CIT0036","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1210\/jc.2016-1460","article-title":"Familial adrenocortical carcinoma in association with Lynch syndrome","volume":"101","author":"Challis","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"18","key":"2022032516104596400_CIT0037","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa043146","article-title":"Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)","volume":"352","author":"Hampel","year":"2005","journal-title":"N Engl J Med."},{"issue":"5","key":"2022032516104596400_CIT0038","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-07-0635","article-title":"Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study","volume":"158","author":"Schaefer","year":"2008","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022032516104596400_CIT0039","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019etude des Tumeurs Endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2022032516104596400_CIT0040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00220544","article-title":"Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis","volume":"89","author":"Seki","year":"1992","journal-title":"Hum Genet."},{"issue":"3","key":"2022032516104596400_CIT0041","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0046-8177(98)90052-1","article-title":"Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histological features","volume":"29","author":"Wakatsuki","year":"1998","journal-title":"Hum Pathol."},{"issue":"6","key":"2022032516104596400_CIT0042","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/DCR.0000000000001008","article-title":"Characteristics of adrenal masses in familial adenomatous polyposis","volume":"61","author":"Shiroky","year":"2018","journal-title":"Dis Colon Rectum."},{"issue":"5","key":"2022032516104596400_CIT0043","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-17-0358","article-title":"Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series","volume":"177","author":"Else","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022032516104596400_CIT0044","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2011-2244","article-title":"A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer","volume":"97","author":"Anselmo","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022032516104596400_CIT0045","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1210\/jc.2011-2321","article-title":"Carney complex with adrenal cortical carcinoma","volume":"97","author":"Morin","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"36","key":"2022032516104596400_CIT0046","doi-asserted-by":"crossref","first-page":"e4756","DOI":"10.1097\/MD.0000000000004756","article-title":"First case report of an adrenocortical carcinoma caused by a BRCA2 mutation","volume":"95","author":"El Ghorayeb","year":"2016","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"2022032516104596400_CIT0047","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/cen.12292","article-title":"An oncocytic adrenal tumour in a patient with Birt-Hogg-Dub\u00e9 syndrome","volume":"80","author":"Raymond","year":"2014","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2022032516104596400_CIT0048","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev."},{"issue":"1","key":"2022032516104596400_CIT0049","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med."},{"issue":"4","key":"2022032516104596400_CIT0050","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"11","key":"2022032516104596400_CIT0051","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer."},{"issue":"2","key":"2022032516104596400_CIT0052","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022032516104596400_CIT0053","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.21873\/anticanres.13395","article-title":"Metastatic carcinomas of the adrenal glands: from diagnosis to treatment","volume":"39","author":"Spartalis","year":"2019","journal-title":"Anticancer Res."},{"issue":"1","key":"2022032516104596400_CIT0054","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/his.13255","article-title":"Challenges in surgical pathology of adrenocortical tumours","volume":"72","author":"Erickson","year":"2018","journal-title":"Histopathology."},{"issue":"2","key":"2022032516104596400_CIT0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ecl.2017.01.007","article-title":"Genetics of adrenocortical development and tumors","volume":"46","author":"Lodish","year":"2017","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"11","key":"2022032516104596400_CIT0056","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jpedsurg.2016.07.014","article-title":"Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: is there a correlation?","volume":"51","author":"Das","year":"2016","journal-title":"J Pediatr Surg."},{"issue":"3","key":"2022032516104596400_CIT0057","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol."},{"issue":"6","key":"2022032516104596400_CIT0058","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12672-011-0088-0","article-title":"The Weiss score and beyond\u2013histopathology for adrenocortical carcinoma","volume":"2","author":"Papotti","year":"2011","journal-title":"Horm Cancer."},{"issue":"12","key":"2022032516104596400_CIT0059","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"2022032516104596400_CIT0060","doi-asserted-by":"crossref","first-page":"e28836","DOI":"10.1002\/pbc.28836","article-title":"Clinical prognostic factors in pediatric adrenocortical tumors: a meta-analysis","volume":"68","author":"Zambaiti","year":"2021","journal-title":"Pediatr Blood Cancer."},{"issue":"6","key":"2022032516104596400_CIT0061","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00383-015-3708-x","article-title":"Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children","volume":"31","author":"Chatterjee","year":"2015","journal-title":"Pediatr Surg Int."},{"issue":"10","key":"2022032516104596400_CIT0062","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022032516104596400_CIT0063","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAI.0b013e31823605e7","article-title":"The use of immunohistochemical expression of SF-1 and EMA in distinguishing adrenocortical tumors from renal neoplasms","volume":"20","author":"Enriquez","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol."},{"issue":"4","key":"2022032516104596400_CIT0064","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PAS.0000000000000574","article-title":"An international Ki67 reproducibility study in adrenal cortical carcinoma","volume":"40","author":"Papathomas","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"2022032516104596400_CIT0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humpath.2015.10.017","article-title":"Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis","volume":"53","author":"Yamazaki","year":"2016","journal-title":"Hum Pathol."},{"issue":"3","key":"2022032516104596400_CIT0066","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022032516104596400_CIT0067","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrendo.2010.235","article-title":"Adrenocortical carcinoma: a clinician\u2019s update","volume":"7","author":"Fassnacht","year":"2011","journal-title":"Nat Rev Endocrinol."},{"issue":"6","key":"2022032516104596400_CIT0068","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1530\/EJE-07-0723","article-title":"Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma","volume":"158","author":"Hermsen","year":"2008","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2022032516104596400_CIT0069","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ejca.2009.12.007","article-title":"The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation","volume":"46","author":"Lughezzani","year":"2010","journal-title":"Eur J Cancer."},{"issue":"11","key":"2022032516104596400_CIT0070","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.4158\/DSCR-2020-0567","article-title":"American Association of Clinical Endocrinology Disease state clinical review on the evaluation and management of adrenocortical carcinoma in an adult: a practical approach","volume":"26","author":"Kiseljak-Vassiliades","year":"2020","journal-title":"Endocr Pract."},{"issue":"2","key":"2022032516104596400_CIT0071","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer."},{"issue":"1","key":"2022032516104596400_CIT0072","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022032516104596400_CIT0073","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/EJE-13-0142","article-title":"Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data","volume":"169","author":"Kerkhofs","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022032516104596400_CIT0074","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00423-011-0866-8","article-title":"Adrenocortical carcinoma: effect of hospital volume on patient outcome","volume":"397","author":"Lombardi","year":"2012","journal-title":"Langenbecks Arch Surg."},{"issue":"10","key":"2022032516104596400_CIT0075","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Lib\u00e9","year":"2015","journal-title":"Ann Oncol."},{"issue":"4","key":"2022032516104596400_CIT0076","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","article-title":"Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer","volume":"65","author":"Berruti","year":"2014","journal-title":"Eur Urol."},{"issue":"6","key":"2022032516104596400_CIT0077","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/EJE-18-0450","article-title":"Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis","volume":"179","author":"Vanbrabant","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"7","key":"2022032516104596400_CIT0078","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"17","key":"2022032516104596400_CIT0079","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"N Engl J Med."},{"issue":"2","key":"2022032516104596400_CIT0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0039-6060(96)80164-4","article-title":"The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group","volume":"119","author":"Crucitti","year":"1996","journal-title":"Surgery."},{"issue":"8","key":"2022032516104596400_CIT0081","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10434-999-0719-7","article-title":"Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma","volume":"6","author":"Schulick","year":"1999","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"2022032516104596400_CIT0082","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0039-6060(05)80119-9","article-title":"Surgical management, DNA content, and patient survival in adrenal cortical carcinoma","volume":"118","author":"Lee","year":"1995","journal-title":"Surgery."},{"key":"2022032516104596400_CIT0083","doi-asserted-by":"crossref","first-page":"A166","DOI":"10.1210\/jendso\/bvab048.336","article-title":"Results of the ADIUVO study, the first randomized trial on adjuvant mitotane in adrenocortical carcinoma patients","volume":"5","author":"Terzolo","year":"2021","journal-title":"J Endocr Soc."},{"issue":"2","key":"2022032516104596400_CIT0084","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12020-019-02141-2","article-title":"The clinical utility of \u2018GRAS\u2019 parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution","volume":"67","author":"Liang","year":"2020","journal-title":"Endocrine."},{"key":"2022032516104596400_CIT0085","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1245\/s10434-020-09562-8","article-title":"Cumulative GRAS score as a predictor of survival after resection for adrenocortical carcinoma: analysis from the U.S. Adrenocortical Carcinoma Database","volume":"28","author":"Baechle","year":"2021","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"2022032516104596400_CIT0086","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin Cancer Res."},{"issue":"7","key":"2022032516104596400_CIT0087","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.2008.18.5678","article-title":"Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival","volume":"27","author":"de Reyni\u00e8s","year":"2009","journal-title":"J Clin Oncol."},{"issue":"1","key":"2022032516104596400_CIT0088","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/EJE-11-0806","article-title":"Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients","volume":"166","author":"Fragoso","year":"2012","journal-title":"Eur J Endocrinol."},{"issue":"11","key":"2022032516104596400_CIT0089","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1158\/1078-0432.CCR-18-2693","article-title":"Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma","volume":"25","author":"Mohan","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"12","key":"2022032516104596400_CIT0090","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2018-01348","article-title":"Targeted molecular analysis in adrenocortical carcinomas: a strategy toward improved personalized prognostication","volume":"103","author":"Lippert","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022032516104596400_CIT0091","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1530\/ERC-21-0040","article-title":"Targeted genomic analysis of 364 adrenocortical carcinomas","volume":"28","author":"Pozdeyev","year":"2021","journal-title":"Endocr Relat Cancer."},{"key":"2022032516104596400_CIT0092","volume-title":"Lysodren (mitotane) [package insert]","year":"1970"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab866\/41987695\/dgab866.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/4\/1159\/42995554\/dgab866.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/4\/1159\/42995554\/dgab866.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T20:51:00Z","timestamp":1648241460000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/4\/1159\/6446871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":92,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,11,30]]},"published-print":{"date-parts":[[2022,3,24]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab866","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,11,30]]}}}